Catalent, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference

SOMERSET, N.J.--()--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that John Chiminski, President & Chief Executive Officer, will present at the 34th Annual J.P. Morgan Healthcare Conference at 10:30 a.m. PT on Monday, January 11, 2016 in San Francisco, CA.

A live webcast of the presentation will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay for 90 days following the event.

About Catalent, Inc.

Catalent, Inc. (NYSE:CTLT) is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs more than 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, please visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

Contacts

Investor Contact:
Catalent, Inc.
Thomas Castellano, 732-537-6325
investors@catalent.com

Contacts

Investor Contact:
Catalent, Inc.
Thomas Castellano, 732-537-6325
investors@catalent.com